Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZEAL | BMY | AMGN | GILD | VRTX |
| Company | Zealand Pharma A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.03 | 70.32 | 243.78 | 82.37 | 315.00 |
| High | 18.07 | 72.61 | 243.78 | 82.50 | 315.78 |
| Low | 17.47 | 69.80 | 236.37 | 80.60 | 304.23 |
| Last | 17.59 | 72.22 | 239.56 | 81.10 | 305.95 |
| Change | +0.21 | +0.99 | -6.85 | -2.90 | -11.32 |
| % Change | +1.21% | +1.39% | -2.78% | -3.45% | -3.57% |
| Volume | 2,100 | 4,866,093 | 1,990,082 | 4,599,402 | 682,542 |
| 20-Day Average Volume | 2,250 | 8,126,202 | 2,313,927 | 6,266,099 | 1,442,870 |
| Previous Close | 17.38 | 71.23 | 246.41 | 84.00 | 317.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 72.43 | 261.79 | 84.60 | 306.40 |
| 20-Day Raw Stochastic | 27.14% | 51.92% | 6.62% | 3.64% | 54.05% |
| 20-Day Relative Strength | 50.34% | 46.51% | 26.68% | 39.66% | 49.46% |
| Weighted Alpha | -38.80 | +6.34 | +1.27 | +30.62 | +23.32 |
| Today's Opinion | 48% Buy | 40% Sell | 8% Sell | 40% Buy | 72% Buy |
| Previous Opinion | 32% Buy | 56% Sell | 8% Sell | 40% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 40% Buy | 80% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 09/21/22 | -0.67% since 01/26/23 | -6.21% since 01/26/23 | -3.28% since 01/26/23 | -4.85% since 01/26/23 |
| Low | 16.54 on 09/27/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.60 on 02/02/23 | 304.23 on 02/02/23 |
| High | 18.07 on 09/29/22 | 73.45 on 01/27/23 | 255.50 on 01/27/23 | 84.65 on 02/01/23 | 325.19 on 01/31/23 |
| 1-Month | |||||
| %Chg | +2.45% since 08/29/22 | +0.76% since 12/30/22 | -8.98% since 12/30/22 | -5.79% since 12/30/22 | +5.77% since 12/30/22 |
| Low | 16.51 on 09/19/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.60 on 02/02/23 | 282.21 on 01/09/23 |
| High | 20.03 on 09/09/22 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 325.19 on 01/31/23 |
| 3-Month | |||||
| %Chg | +32.96% since 06/29/22 | -6.39% since 11/02/22 | -11.14% since 11/02/22 | +3.85% since 11/02/22 | -1.47% since 11/02/22 |
| Low | 12.82 on 07/01/22 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 77.16 on 11/03/22 | 282.21 on 01/09/23 |
| High | 20.49 on 08/25/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| 6-Month | |||||
| %Chg | +20.23% since 03/29/22 | -1.06% since 08/02/22 | -1.99% since 08/02/22 | +35.84% since 08/02/22 | +11.53% since 08/02/22 |
| Low | 9.93 on 05/16/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.62 on 08/05/22 | 271.61 on 08/03/22 |
| High | 20.49 on 08/25/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 818,603 | 151,446,384 | 131,479,200 | 105,356,496 | 81,440,352 |
| Shares Outstanding, K | 46,538 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 46,550,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -161,990,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 4,060,000 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -69,960,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | 1.45 | 0.43 | 0.64 | 0.39 | 0.47 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 08/11/22 | 1.99 on 10/25/22 | 4.09 on 01/31/23 | 1.90 on 10/27/22 | 4.01 on 10/27/22 |
| Latest Earnings Date | 11/10/22 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.42 | 14.27 | 13.35 | 24.46 |
